Viewing data from:

VERSAPEN

ANDA

HETACILLIN | A061398 | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO

2 strengths0 unique patents0 unique exclusivities

API Supply Chain0 active DMFs2 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

BARCELONETA INC DIV BRISTOL MYERSInactiveHETACILLIN ACID

DMF 134221998

BRISTOL MYERS SQUIBB COInactiveHETACILLIN

DMF 134271998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 112.5MG AMPICIL/ML

0 patents0 exclusivities▴

FOR SUSPENSION;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.

#002 — EQ 225MG AMPICIL/5ML

0 patents0 exclusivities▾

FOR SUSPENSION;ORAL | Approved: Approved Prior to Jan 1, 1982